Recent News and Updates
Ochsner Health named Wilson Disease Association Center of Excellence
Ochsner Health has been named a Center of Excellence by the Wilson Disease Association, recognizing its leadership in the management of Wilson disease. Click here to read more.
Orphalan Partners with MAP International and the Wilson Disease Association to Provide Life-Changing Medicine to Underserved Communities
Orphalan SA, a global pharmaceutical company focused on rare diseases, is partnering with MAP International and the Wilson Disease Association (WDA) to provide Cuvrior® (trientine tetrahydrochloride) to patients with Wilson Disease in developing countries. Through [...]
Important change for Wilson disease patients taking Galzin
WD Patients taking prescription zinc can now get their Galzin from a specialty pharmacy […]
WDA designates Wilson Disease Center of Excellence at University of Miami
Read more: Press Release
Ultragenyx letter to the WD community
Read more: WDA Community Update from Ultragenyx Oct 2024 (PDF)


